Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE (CARES-Lite)
Cancer, Depression, Fatigue
About this trial
This is an interventional supportive care trial for Cancer focused on measuring Cancer Depression Fatigue Pain
Eligibility Criteria
Inclusion Criteria: Patients: Biopsy and/or radiograph proven diagnosis of hepatocellular carcinoma, cholangiocarcinoma, gallbladder carcinoma or breast, ovarian, or colorectal cancer with liver metastases with a life expectancy of at least one year; age >21 years; no evidence of thought disorder, delusions, or active suicidal ideation is observed or reported. Caregivers: A spouse or cohabitating intimate partner of an advanced cancer patient being evaluated the UPMC's Liver Cancer Center and age >21 years Exclusion Criteria: Patients: Age < 21 years, Lack of fluency in English, Evidence of thought disorder, delusions, hallucinations, or suicidal ideation. Caregivers: Age < 21 years, Lack of fluency in English, Evidence of thought disorder, delusions, hallucinations, or suicidal ideation.
Sites / Locations
- University of Pittsburgh Medical Center Montefiore Liver Cancer CenterRecruiting
- University of Pittsburgh's Medical Center Montefiore HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Stepped collaborative care intervention
Enhanced Usual Care
The 'Stepped Collaborative Care Intervention' includes at least biweekly contact from a care coordinator by phone and face to face visits occurring approximately every 2 months, and 24 hour 7 day a week access to a website that was specifically designed during the pilot study for advanced cancer patients from socioeconomically disadvantaged backgrounds.
Patients randomized to the 'Enhanced Usual Care' arm receive their usual care from their medical team. However, if the patient scores in the clinical range on one or more of the three symptoms s/he will receive education about the symptom and be referred to the appropriate health care provider for further treatment in their community. The care coordinator will follow up with the patient after 3 weeks to assess barriers to treatment and assist further with accessing treatment if needed.